Insider Trading February 26, 2026

Director Sells Small Stake in American Superconductor Amid Recent Volatility

Oliver disposes of 200 AMSC shares as the company posts a strong fiscal Q3 while the stock trades well below its 52-week high

By Avery Klein AMSC
Director Sells Small Stake in American Superconductor Amid Recent Volatility
AMSC

A company director sold 200 shares of American Superconductor Corporation (AMSC) on February 24, 2026, in a transaction disclosed on an SEC Form 4. The sale occurred at $34.10 per share for a total of $6,820. The transaction comes as the stock trades below its 52-week peak and after the company reported a sizable third-quarter earnings beat for fiscal 2025.

Key Points

  • Director Oliver David R Jr. sold 200 AMSC shares on February 24, 2026, at $34.10 per share, totaling $6,820.
  • After the sale, Oliver holds 60,707 shares; the transaction was reported on an SEC Form 4 and characterized as for tax planning purposes.
  • American Superconductor beat fiscal Q3 2025 expectations with EPS of $2.81 versus $0.15 expected and revenue of $74 million, up 20% year-over-year; InvestingPro analysis indicates the stock appears overvalued.

Transaction details

Director Oliver David R Jr. sold 200 shares of AMERICAN SUPERCONDUCTOR CORP (NASDAQ: AMSC) on February 24, 2026. The shares were sold at $34.10 each, producing gross proceeds of $6,820. At the time of the report the stock was trading at $34.64.

Shareholding after sale and regulatory notice

Following the disposition, Oliver directly holds 60,707 shares of the company’s common stock. The sale was disclosed in a Form 4 filing submitted to the Securities and Exchange Commission.

Context on stock performance

The company’s shares are trading well below their 52-week high of $70.49. The article notes a difficult six-month stretch that included a 34% decline in the share price.

Stated reason for the sale

The Form 4 filing states that the reported sales were executed by the reporting person for tax planning purposes.

Valuation note

According to InvestingPro analysis cited in the filing summary, AMSC currently appears overvalued relative to its Fair Value. The same note indicates there are 13 additional ProTips available to subscribers of that service.

Recent financial results

American Superconductor reported third-quarter results for fiscal year 2025 that included earnings per share of $2.81, materially above the expected $0.15. The company’s EPS outperformance represents a 1773.33% surprise relative to the consensus figure cited. Revenue for the quarter reached $74 million, which the report states both exceeded expectations and represented a 20% increase from the same quarter a year earlier.

Market and analyst reaction

The article notes that analysts from multiple firms took note of the quarter’s results and that some adjusted their outlooks on the company. It also states the earnings report has drawn investor attention and reflects a strong market response during the reporting period.


Summary

A director sale of 200 AMSC shares for $6,820 was reported on Form 4. The transaction occurred against a backdrop of a notable quarterly earnings beat and ongoing share-price weakness relative to the 52-week high. Valuation commentary from InvestingPro is cited as indicating AMSC is currently overvalued relative to its Fair Value.

Risks

  • Shares are trading well below the 52-week high of $70.49 and have declined 34% over the past six months, indicating recent price volatility - this affects equity investors and public markets.
  • InvestingPro analysis cited in the report indicates AMSC appears overvalued relative to its Fair Value, presenting valuation risk for potential buyers and existing shareholders in the equity market.
  • The Form 4 notes the sale was made for tax planning purposes, which leaves uncertainty about the director’s longer-term intentions despite the stated rationale - this introduces an element of ambiguity for investors monitoring insider activity.

More from Insider Trading

Vertex Executive Sells Nearly $1.6M in Stock Across Two Days Feb 26, 2026 Krystal Biotech Director Executes $10.1M Stock Sale, Exercises Options Under 10b5-1 Plan Feb 26, 2026 Vertex Executive Sells $2.39M in Stock as Company Nears 52-Week High Feb 26, 2026 Exelixis Executive Sells $2.13M in Stock as Firm Posts Mixed Q4 Results Feb 26, 2026 Mueller Water Products Director Purchases $739,415 of Stock as Results Beat Estimates Feb 26, 2026